Cite
Dupilumab improves health‐related quality of life in patients with chronic rhinosinusitis with nasal polyposis.
MLA
Bachert, Claus, et al. “Dupilumab Improves Health‐related Quality of Life in Patients with Chronic Rhinosinusitis with Nasal Polyposis.” Allergy, vol. 75, no. 1, Jan. 2020, pp. 148–57. EBSCOhost, https://doi.org/10.1111/all.13984.
APA
Bachert, C., Hellings, P. W., Mullol, J., Hamilos, D. L., Gevaert, P., Naclerio, R. M., Joish, V. N., Chao, J., Mannent, L. P., Amin, N., Abbe, A., Taniou, C., Fan, C., Pirozzi, G., Graham, N. M. H., Mahajan, P., Staudinger, H., & Khan, A. (2020). Dupilumab improves health‐related quality of life in patients with chronic rhinosinusitis with nasal polyposis. Allergy, 75(1), 148–157. https://doi.org/10.1111/all.13984
Chicago
Bachert, Claus, Peter W. Hellings, Joaquim Mullol, Daniel L. Hamilos, Philippe Gevaert, Robert M. Naclerio, Vijay N. Joish, et al. 2020. “Dupilumab Improves Health‐related Quality of Life in Patients with Chronic Rhinosinusitis with Nasal Polyposis.” Allergy 75 (1): 148–57. doi:10.1111/all.13984.